Cargando…

Fulminant myocarditis: COVID or not COVID? Reinfection or co-infection?

We describe a unique case of fulminant myocarditis in a patient with presumed SARS-CoV-2 reinfection. Patient had initial infection 4 months backand had COVID-19 antibody at the time of presentation. Endomyocardial biopsy showed lymphocytic myocarditis, that is usually seen in viral myocarditis. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yeleti, Ramya, Guglin, Maya, Saleem, Kashif, Adigopula, Sasikanth V, Sinha, Anjan, Upadhyay, Smrity, Everett, Jeffrey E, Ballut, Kareem, Uppuluri, Sarada, Rao, Roopa A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919708/ https://www.ncbi.nlm.nih.gov/pubmed/33615872 http://dx.doi.org/10.2217/fca-2020-0237

Ejemplares similares

Clinical variants of myocardial involvement in COVID-19-positive patients: a cumulative experience of 2020
por: Guglin, Maya, et al.
Publicado: (2021)

CLINICAL VARIANTS OF MYOCARDIAL INVOLVEMENT IN COVID-19 POSITIVE PATIENTS
por: Guglin, Maya E., et al.
Publicado: (2021)

CLINICAL CHARACTERISTICS, OUTCOMES AND IMMUNOSUPPRESSION STRATEGIES OF HEART TRANSPLANT RECIPIENTS INFECTED WITH COVID-19
por: Ilonze, Onyedika J., et al.
Publicado: (2021)

Fulminant Myocarditis and Cardiogenic Shock Following COVID-19 Infection Versus COVID-19 Vaccination: A Systematic Literature Review
por: Guglin, Maya E., et al.
Publicado: (2023)

SARS-CoV-2 infection in heart transplant recipients: a systematic literature review of clinical outcomes and immunosuppression strategies
por: Ilonze, Onyedika J., et al.
Publicado: (2021)

Calcineurin-Inhibitor Induced Pain Syndrome in a Heart Transplant Patient
por: Ilonze, Onyedika J., et al.
Publicado: (2021)

Fulminant myocarditis and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

COVID-Induced Fulminant Myocarditis
por: Rodriguez Guerra, Miguel A, et al.
Publicado: (2022)

(566) Cardiogenic Shock with Fulminant Myocarditis Following Covid-19 Infection Tends to Have Slightly Worse Outcome Than That From Covid-19 Vaccinations
por: Etuk, A., et al.
Publicado: (2023)

Fulminant myocarditis and COVID-19. Response
por: Irabien-Ortiz, Ángela, et al.
Publicado: (2020)

Fulminant myocarditis due to COVID-19
por: Irabien-Ortiz, Ángela, et al.
Publicado: (2020)

Myocarditis Following Covid-19 Vaccination In Adolescents And Adults In 2021
por: Ilonze, Onyedika J, et al.
Publicado: (2023)

A Unique Case of Systemic Lupus Erythematosus Myocarditis Complicated by Plasmapheresis-Responsive Cardiogenic Shock
por: Smith, Carson, et al.
Publicado: (2020)

Myocarditis following COVID-19 vaccination in adolescents and adults: a cumulative experience of 2021
por: Ilonze, Onyedika J., et al.
Publicado: (2022)

COVID-19 fulminant myocarditis: a case report
por: Bernal-Torres, Wikler, et al.
Publicado: (2020)

Detailed hemodynamics of fulminant myocarditis caused by COVID-19
por: Imamura, Teruhiko
Publicado: (2020)

FULMINANT MYOCARDITIS-A UNIQUE COMPLICATION OF COVID-19
por: Ahmed, Anas, et al.
Publicado: (2021)

Early characteristics of fulminant myocarditis vs non-fulminant myocarditis: A meta-analysis
por: Wang, Zicheng, et al.
Publicado: (2019)

Fulminant and Non-fulminant Clinical COVID-19 Myocarditis in the New York City Area in 2020
por: Wong, Christopher, et al.
Publicado: (2022)

Fulminant myocarditis and atrial fibrillation in child with acute COVID-19
por: Kohli, Utkarsh, et al.
Publicado: (2022)

Heart Transplantation to Fulminant Myocarditis during COVID-19 Outbreak
por: Wiwanitkit, Viroj
Publicado: (2020)

An Atypical Presentation of Fulminant Myocarditis Secondary to COVID-19 Infection
por: Richard, Ivan, et al.
Publicado: (2020)

Fulminant COVID-19-Associated Myocarditis in an Otherwise Healthy Female
por: Milla-Godoy, Gabriela C, et al.
Publicado: (2021)

Pheochromocytoma presenting as fulminant myocarditis mimicking COVID‐19 pneumonia
por: Rojbi, Imen, et al.
Publicado: (2021)

Case Report: COVID-19 Vaccination Associated Fulminant Myocarditis
por: Cui, Guanglin, et al.
Publicado: (2022)

Fulminant myocarditis in COVID-19 and favorable outcomes with VA-ECMO
por: Bhardwaj, Abhishek, et al.
Publicado: (2022)

Successful Treatment of Fulminant Myocarditis with Intracardiac Thrombus in COVID-19
por: Mejia, E.J., et al.
Publicado: (2022)

FULMINANT MYOCARDITIS IN COVID-19 WITH RAPID RECOVERY OF SYSTOLIC FUNCTION
por: Calhoun, Avery, et al.
Publicado: (2021)

Phenotypic Heterogeneity of Fulminant COVID-19--Related Myocarditis in Adults
por: Barhoum, Petra, et al.
Publicado: (2022)

Fulminant Myocarditis and Acute Appendicitis after COVID-19 Vaccination
por: Kawano, Hiroaki, et al.
Publicado: (2022)

Fulminant myocarditis in the time of coronavirus
por: Cuomo, Vittoria, et al.
Publicado: (2020)

COVID-19-Related Myocarditis: Are We There Yet? A Case Report of COVID-19-Related Fulminant Myocarditis
por: Pierri, Alessandro, et al.
Publicado: (2023)

Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis
por: Kow, Chia Siang, et al.
Publicado: (2020)

COVID-19–Associated Fulminant Myocarditis: Pathophysiology-Related Phenotypic Variance
por: Nair, Ajith, et al.
Publicado: (2022)

COVID-19 infection with complicated fulminant myocarditis: a case report
por: Miao, Kun, et al.
Publicado: (2023)

Transient Myocarditis Associated with Fulminant Colitis
por: Williamson, J. M. L., et al.
Publicado: (2011)

Fulminant Guillain-Barré Syndrome with Myocarditis
por: Mishra, Ajay, et al.
Publicado: (2014)

Fulminant myocarditis: Characteristics, treatment, and outcomes
por: Veronese, Giacomo, et al.
Publicado: (2018)

Consideration on pathogen of viral fulminant myocarditis
por: Wei, Xin, et al.
Publicado: (2020)

Fulminant Eosinophilic Myocarditis and VT Storm
por: Hoppens, Kyle R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vonc4t6taa89ot52p6rv50j0hk